Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14196379Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2025
Linked Award Amount
$1.7M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#8,516
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Andrew Riley as a PI. Multi-PI records show the full award amount for context.
- 5R01DA057961-02R01Selective Targeting of Nicotinic Acetylcholine Receptor Subtypes for Cocaine Use Disorder$689Kaward amount
- 5R01NS134647-02R01α9α10 Nicotinic Acetylcholine Receptors in neuropathic pain$624.4Kaward amount
- 5R35GM147005-04R35Synthesis and Evaluation of Alkaloids to Probe Membrane Receptors$378.2Kaward amount
- 3R35GM147005-04S1R35Synthesis and Evaluation of Alkaloids to Probe Membrane Receptors$6.1Kaward amount
Award organization
Organizations that administered FY2025 awards listing Andrew Riley as a PI.
FY2025 award administered by University of Illinois at Chicago (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Illinois at Chicago
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5191
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #4380
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Andrew Riley.